CRLCharles River Laboratories International Inc.
CRL
Charles River Laboratories International Inc.912
Mkt Cap
$10.64BVolume
1.13M52W High
$217.8952W Low
$91.86PE Ratio
-138.59CRL Fundamentals
Price
$220.91Prev Close
$215.51Open
$217.8250D MA
$185.60Beta
1.42Avg. Volume
675,251.82EPS (Annual)
$0.1994P/B
3.11Rev/Employee
$201,491.99Tempus AI Stock Surges 82.4% in a Year: What's Driving It?
TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.
Zacks·10h ago
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that James C. (Jim) Foster, Chair, President, and Chief Executive Officer (CEO), plans to retire, effective on May 5, 2026...
Business Wire·1d ago
What Makes Charles River (CRL) a New Buy Stock
Charles River (CRL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·3d ago
Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue?
Charles River (CRL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·3d ago
Charles River Laboratories International (NYSE:CRL) Hits New 1-Year High - Here's Why
Charles River Laboratories International (NYSE:CRL) Reaches New 1-Year High - Should You Buy...
MarketBeat·4d ago
Allspring Global Investments Holdings LLC Sells 113,185 Shares of Charles River Laboratories International, Inc. $CRL
Allspring Global Investments Holdings LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% during the third quarter, according to...
MarketBeat·10d ago
Charles River Laboratories International, Inc. $CRL Shares Purchased by Boston Trust Walden Corp
Boston Trust Walden Corp raised its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.4% during the third quarter, according to the company in its most recent...
MarketBeat·11d ago
Charles River Laboratories International (NYSE:CRL) Reaches New 52-Week High - Time to Buy?
Charles River Laboratories International (NYSE:CRL) Hits New 1-Year High - Should You Buy...
MarketBeat·11d ago
Charles River Laboratories International, Inc. $CRL Stake Cut by Norris Perne & French LLP MI
Norris Perne & French LLP MI lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 92.0% during the 3rd quarter, according to the company in...
MarketBeat·11d ago
Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the...
MarketBeat·12d ago
<
1
2
...
>